BioengineeringbioRxivPreprint
In vivo engineered quadrivalent CAR-macrophages break tumor barrier,remodel TME and overcome tumor heterogeneity through antigen spreading
Shaolong Zhang, Hengxing Lu, Hailing Zhang…·Jin Zhang
This study develops in vivo engineered quadrivalent CAR-macrophages that break tumor barriers, remodel the TME, and overcome tumor heterogeneity through antigen spreading, achieving complete tumor regression.